Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
OraSure Technologies
MedTech
OraSure sees investor pressure, potential proxy fight: report
Infectious disease testmaker OraSure may have a fight brewing over its board of directors following the recent rejection of a buyout offer.
Conor Hale
Sep 9, 2025 12:00pm
HHS invests $560M to boost COVID-19 test supply
Oct 25, 2021 9:38am
OraSure nabs $109M in DOD funding to churn out COVID tests
Oct 4, 2021 9:55am
BARDA funds OraSure's home spit test for coronavirus infections
Apr 7, 2020 10:48am
